Related Experiment Video
Updated: Jul 27, 2026

Assaying Locomotor, Learning, and Memory Deficits in Drosophila Models of Neurodegeneration
Published on: March 11, 2011
Drosophila as an Animal Model To Determine the Functional and Behavioral Significance of Dopamine Transporter Genetic
Samuel J Mabry1, Angela M Carter1,2, Aurelio Galli3,4
1UAB Department of Surgery, Birmingham, AL, USA.
Abstract:
Drosophila melanogaster, commonly referred to as the "fruit fly," has been a long-utilized animal model in multiple areas of biological research. It is estimated that 75% of human genes, which are associated with disease, have homologues in Drosophila. The conservation of biological systems, the genetic tractability, short generation time, and a broad array of available behavioral assessments make Drosophila an especially robust model organism for neuroscience investigations. The dopamine (DA) system, in particular, is highly conserved between mammals and Drosophila. Mutations of the DA transporter (DAT), a negative regulator of DA neurotransmission, have been associated with multiple different neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASDs), attention deficit hyperactivity disorder (ADHD), and Parkinson's disease (PD). Utilization of Drosophila models demonstrates specific structural and functional alterations in mutated DAT that manifest as unique behavioral phenotypes. Ultimately, combining techniques ranging from biochemistry, electrochemistry, and complex behavioral analyses facilitated a deeper understanding of how transporter function and dysfunction can translate to neurological and neuropsychiatric disorders.
More Related Videos
09:17Assessing Neurodegenerative Phenotypes in Drosophila Dopaminergic Neurons by Climbing Assays and Whole Brain Immunostaining
Published on: April 24, 2013
10:13Dissection and Immunofluorescent Staining of Mushroom Body and Photoreceptor Neurons in Adult Drosophila melanogaster Brains
Published on: November 6, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Gut-Brain Axis